The Global Institute for Novel Nicotine (GINN) is pleased to welcome CLEW, a leading brand in modern oral nicotine pouches, as its latest founding member. This partnership marks a significant step forward in GINN's mission to promote reduced-risk nicotine products and evidence-based practices within the industry.
CLEW, manufactured by Nevcore Innovations Inc., has recently achieved a milestone with the acceptance of its Premarket Tobacco Product Application (PMTA) by the U.S. Food and Drug Administration. This accomplishment underscores CLEW's commitment to providing high-quality, smoke-free alternatives for adult nicotine consumers. The brand is poised for global expansion, bringing its innovative nicotine pouches to a wider audience and supporting harm reduction efforts worldwide.
In addition to its membership, CLEW will actively support GINN's conferences and events, enhancing collaborative efforts within the sector. Dr Aditya Shukla, CLEW's Head of Research & Development, will also support GINN's research agenda, bringing valuable expertise to further the organisation's mission.
Waqas Khan, Global CEO of CLEW, said:
"We are honoured to join GINN as a founding member. Our goal has always been to lead in harm reduction by offering nicotine products that are both satisfying and responsible.
"CLEW nicotine pouches herald a new era in nicotine satisfaction, and we are confident they will set the new global benchmark for white nicotine pouches the world over. We have listened to the needs and desires of consumers and have developed a product that not only meets but exceeds their expectations, which will play a significant role in global harm reduction efforts.
“With the support of GINN, we are excited to contribute to the development of better industry standards and to advocate for the benefits of reduced-risk nicotine products."
Shem Baldeosingh, Director of GINN, said:
"GINN stands to benefit from CLEW’s unstinting support for reduced-risk products. Waqas Khan is a regular contributor at various international nicotine events and his global speaking engagements will enable him to act as one of GINN’s spokespersons.
“Additionally, we are both aligned on the need for responsible legislation of nicotine pouches and our work together will advance GINN’s regulatory advocacy in markets around the world.”
ENDS
Notes to Editors:
For more information or journalist queries, please contact Tommy Gilchrist on +44 (0) 7388 110 679 or via [email protected].
About GINN:
The Global Institute for Novel Nicotine (GINN) is dedicated to positioning itself as the industry's primary advocate for non-vaping reduced-risk products. While vapes have established representation, GINN focuses on emerging reduced-risk products like nicotine pouches and heat-not-burn. As a membership-based association, GINN engages with stakeholders globally, and has an evidence-based and science-led approach at the heart of all that it does.
About CLEW:
CLEW is a premium brand of modern oral nicotine pouches, committed to providing a cleaner, smoke-free alternative for adult nicotine users. Manufactured by Nevcore Innovations Inc., CLEW products are crafted with pharmaceutical-grade nicotine and a range of flavours, offering a discreet and satisfying experience. CLEW is at the forefront of nicotine harm reduction, aiming to set new benchmarks in the industry.
